Yi Su

Dr. Yi Su

Hunan Normal University, Changsha, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2016 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
YSYi Su
Yi Su
JLJ. Leung
J. Leung
DHD. Hans
D. Hans
OLO. Lamy
O. Lamy
TKTimothy Kwok
Timothy Kwok

15 April 2022 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
XZX. Zeng
X. Zeng
YSYi Su
Yi Su
ATA. Tan
A. Tan
LZL. Zou
L. Zou
WZW. Zha
W. Zha
TKT. Kwok
T. Kwok

12 May 2022 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
YSYi Su
Yi Su
SYSuey S.Y. Yeung
Suey S.Y. Yeung
Yuming ChenYuming Chen
Yuming Chen
JLJason C.S. Leung
Jason C.S. Leung
TKTimothy Kwok
Timothy Kwok

5 August 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
FLFreddy Man Hin Lam
Freddy Man Hin Lam
YSYi Su
Yi Su
ZLZhi-Hui Lu
Zhi-Hui Lu
RYRuby Yu
Ruby Yu
JLJason C.S. Leung
Jason C.S. Leung
TKTimothy Kwok
Timothy Kwok

11 October 2016 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
YSYi Su
Yi Su
JLJ. Leung
J. Leung
DHD. Hans
D. Hans
BAB. Aubry-Rozier
B. Aubry-Rozier
TKTimothy Kwok
Timothy Kwok

1 March 2024 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
LLLinghong Li
Linghong Li
ZXZhilin Xia
Zhilin Xia
XZXueqing Zeng
Xueqing Zeng
ATAnfen Tang
Anfen Tang
LWLing Wang
Ling Wang
YSYi Su
Yi Su
Background: The measurement or estimation of muscle mass plays an important role in the diagnosis of sarcopenia. Beside dual-energy X-ray absorptiometry (DXA), several modalities, including bioelectrical impedance analysis (BIA), ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), have helped to provide imaging or electrical biomarkers for muscle mass. This study was aimed at summarizing the diagnostic performance of different techniques on muscle assessment for sarcopenia. Methods: Studies on the assessment of muscle mass by different techniques (compared with DXA), published from inception to 12 October, 2023 were retrieved from 4 electronic databases: the Cochrane Library, Embase, PubMed, and Web of Science. The quality assessment of included studies was conducted using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). The sensitivity, specificity, Cohen’s kappa coefficient (κ), and Pearson correlation coefficient (r) with 95% confidence intervals (CIs) were pooled and presented via forest plots. The area under the curve (AUC) with 95% CI was pooled and presented via summary receiver operating characteristic (sROC) curve. Results: A total of 28 studies involving 4,926 participants were included. Compared with DXA, the pooled sensitivity and specificity, AUC, and Cohen’s κ were 0.79 (95% CI: 0.71–0.86, P<0.001), 0.95 (95% CI: 0.82–0.99, P<0.001), and 0.88 (95% CI: 0.85–0.90), and 0.61 (95% CI: 0.51–0.72) for BIA. The pooled r value between DXA and BIA or US or MRI was 0.94 (95% CI: 0.92–0.96, P<0.001), 0.69 (95% CI: 0.54–0.80, P<0.001), and 0.96 (95% CI: 0.95–0.97, P=0.21), respectively. No qualified original study in relation to CT was included. Conclusions: BIA, US, and MRI would provide acceptable diagnostic accuracy for sarcopenia by evaluating muscle mass in terms of sensitivity, specificity, accuracy, and their higher correlations with DXA. Further investigation is required to elucidate the value of CT in diagnosing sarcopenia.